(Q54419664)

English

Inflammatory gene expression in monocytes of patients with schizophrenia: overlap and difference with bipolar disorder. A study in naturalistically treated patients.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/20633309

Inflammatory gene expression in monocytes of patients with schizophrenia: overlap and difference with bipolar disorder. A study in naturalistically treated patients. (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/20633309

0 references

0 references

bipolar disorder

1 reference

based on heuristic

inferred from title

author name string

Roosmarijn C Drexhage

1

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/20633309

Leonie van der Heul-Nieuwenhuijsen

2

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/20633309

Roos C Padmos

3

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/20633309

Nico van Beveren

4

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/20633309

Dan Cohen

5

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/20633309

Marjan A Versnel

6

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/20633309

Willem A Nolen

7

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/20633309

Hemmo A Drexhage

8

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/20633309

publication date

15 July 2010

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/20633309

The International Journal of Neuropsychopharmacology

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/20633309

13

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/20633309

10

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/20633309

1369-1381

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/20633309

The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000799

21 January 2018

Early growth response transcriptional regulators are dispensable for macrophage differentiation.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000799

21 January 2018

The common genetic liability between schizophrenia and bipolar disorder: a review

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000799

21 January 2018

The antidepressant and antiinflammatory effects of rolipram in the central nervous system

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000799

21 January 2018

Small Maf proteins in mammalian gene control: mere dimerization partners or dynamic transcriptional regulators?

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000799

21 January 2018

Is autoimmune thyroiditis part of the genetic vulnerability (or an endophenotype) for bipolar disorder?

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000799

21 January 2018

Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000799

21 January 2018

Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using 'real-time' quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR) - a Europe against cancer program.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000799

21 January 2018

A switch from Myc:Max to Mad:Max heterocomplexes accompanies monocyte/macrophage differentiation.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000799

21 January 2018

Association between the TRAX/DISC locus and both bipolar disorder and schizophrenia in the Scottish population

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000799

21 January 2018

The Comprehensive Assessment of Symptoms and History (CASH). An instrument for assessing diagnosis and psychopathology.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000799

21 January 2018

Celecoxib as adjunctive therapy in schizophrenia: a double-blind, randomized and placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000799

21 January 2018

Wnt target genes identified by DNA microarrays in immature CD34+ thymocytes regulate proliferation and cell adhesion.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000799

21 January 2018

The macrophage-T-lymphocyte theory of schizophrenia: Additional evidence

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000799

21 January 2018

Effects of antipsychotic drugs on cytokine networks

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000799

21 January 2018

Distinct monocyte gene-expression profiles in autoimmune diabetes

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000799

21 January 2018

A discriminating messenger RNA signature for bipolar disorder formed by an aberrant expression of inflammatory genes in monocytes.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000799

21 January 2018

A high prevalence of organ-specific autoimmunity in patients with bipolar disorder

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000799

21 January 2018

Diagnosis of functional psychoses: time to face the future

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000799

21 January 2018

Celecoxib as an adjunct in the treatment of depressive or mixed episodes of bipolar disorder: a double-blind, randomized, placebo-controlled study.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000799

21 January 2018

COX-2 inhibition as a treatment approach in schizophrenia: immunological considerations and clinical effects of celecoxib add-on therapy

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000799

21 January 2018

The world according to Maf

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000799

21 January 2018

Cilomilast: orally active selective phosphodiesterase-4 inhibitor for treatment of chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000799

21 January 2018

Microarray analysis of human leucocyte subsets: the advantages of positive selection and rapid purification

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000799

21 January 2018

Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a population-based study

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000799

21 January 2018

A relative resistance of T cells to dexamethasone in bipolar disorder.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000799

21 January 2018

The MAX-interacting transcription factor network

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000799

21 January 2018

Association of schizophrenia and autoimmune diseases: linkage of Danish national registers

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000799

21 January 2018

Cytokines in schizophrenia and the effects of antipsychotic drugs

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000799

21 January 2018

Maximum significance clustering of oligonucleotide microarrays.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000799

21 January 2018

Opposing regulation of T cell function by Egr-1/NAB2 and Egr-2/Egr-3.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000799

21 January 2018

The level of cardiovascular risk factors in bipolar disorder equals that of schizophrenia: a comparative study

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000799

7 January 2021

based on heuristic

inferred from DOI database lookup

The Stanley Foundation Bipolar Treatment Outcome Network

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000799

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of the COX-2 inhibitor celecoxib on behavioural and immune changes in an olfactory bulbectomised rat model of depression

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000799

7 January 2021

based on heuristic

inferred from DOI database lookup

Patients with schizophrenia show raised serum levels of the pro-inflammatory chemokine CCL2: association with the metabolic syndrome in patients?

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000799

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1017/S1461145710000799

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/20633309

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/20633309

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54419664&oldid=1444893143"